✦ LIBER ✦

Retrospective Evaluation of Clinical Outcomes in Patients with HER2-Positive Advanced Breast Cancer Progressing on Trastuzumab-Based Therapy in the Pre-Lapatinib Era

✍ Scribed by Filippo Montemurro; Stefania Redana; Giuseppe Viale; Giuseppina Sanna; Michela Donadio; Giorgio Valabrega; Barbara del Curto; Alberto Bottini; Gerardo Botti; Angelo Paolo dei Tos; Maria Elena Jacomuzzi; Maurizio Di Bonito; Saverio Danese; Matteo Clavarezza; Janina Kulka; Silvana Di Palma; Antonio Durando; Anna Sapino; Massimo Aglietta

Book ID: 115075802
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 123 KB
Volume: 8
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2008.n.053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase Ib Study of Buparlisib plus Trastu

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

✍ Saura, C.; Bendell, J.; Jerusalem, G.; Su, S.; Ru, Q.; De Buck, S.; Mills, D.; R 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 898 KB

Clinical outcomes and treatment practice

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era

✍ Olson, Erin M.; Najita, Julie S.; Sohl, Jessica; Arnaout, Amal; Burstein, Harold 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 695 KB

Effect of adjuvant/neoadjuvant trastuzum

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer

✍ Murthy, Rashmi K.; Varma, Ankur; Mishra, Priyankana; Hess, Kenneth R.; Young, El 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Trastuzumab Emtansine: A Review of Its U

Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy

✍ Dhillon, Sohita 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 402 KB

Phase II evaluation of the efficacy and

Phase II evaluation of the efficacy and safety of trastuzumab plus pertuzumab therapy in patients with HER2-positive metastatic breast cancer that had progressed during trastuzumab treatment

✍ J. Cortes; K. Gelmon; P. Fumoleau; A. Wardley; S. Verma; P.F. Conte; L. Gianni; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

5088 Analysis of factors predicting resp

5088 Analysis of factors predicting response to second-line trastuzumab- based therapy in patients (pts) with Her2-positive advanced breast cancer (ABC)

✍ R. Bartsch; C. DeVries; U. Pluschnig; P. Dubsky; S. Horvath; M. Rudas; R.M. Made 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB